author-photo

Changsong Qi

Peking University

48

Papers

288

Citations

Citation Trend

Filter By

Papers (39) Sort By

Journal Conference Others

1414P Helicobacter pylori infection is associated with clinical benefits of anti-PD-1/PD-L1-based therapies in advanced gastric/esophagogastric junction cancer: A real world multicenter observational study

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Molecular characterization of ctDNA from Chinese patients with advanced gastric adenocarcinoma reveals actionable alterations for targeted and immune therapy.

2021 Journal of Molecular Medicine
Show All
- Source
- Cite
- Save
Citations (1)
The Inconsistent and Inadequate Reporting Of Immune-Related Adverse Events in PD-1/PD-L1 Inhibitors: A Systematic Review of Randomized Controlled Clinical Trials.

2021 Oncologist
Show All
- Source
- Cite
- Save
Citations (1)
Response to the rechallenge of combination immunotherapy in a patient with late-stage gastric cancer: case report.

2021 Annals of palliative medicine
Show All
- Source
- Cite
- Save
Citations (0)
Clinicopathological Characteristics and Prognosis of Signet Ring Gastric Cancer: A Population-Based Study.

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (0)
1372O CLDN 18.2-targeted CAR-T cell therapy in patients with cancers of the digestive system

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Clinicopathological Characteristics and Response to Chemotherapy in Treatment-Naive Epstein–Barr Virus Associated Gastric Cancer: A Retrospective Study

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Appropriate PD-L1 Cutoff Value for Gastric Cancer Immunotherapy: A Systematic Review and Meta-Analysis.

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

2021 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer.

2021 Cancer biology and medicine
Show All
- Source
- Cite
- Save
Citations (0)